Skip to main content
  • Important Safety Information
  • Prescribing Information
  • Instructions for Use

    • The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE and return to the consumer section of the site.

    Yes, I am a US healthcare professional and would like to continue

    Continue
  • For US Healthcare Professionals

TYVASO is approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

SELECT A CONDITION
Skip to main content
Hamburger button
Close button
SELECT A CONDITION

UNDERSTANDING PH-ILD

View sub items for UNDERSTANDING PH-ILD

ABOUT TYVASO

View sub items for ABOUT TYVASO

WHY TAKE TYVASO?

View sub items for WHY TAKE TYVASO?

TAKING TYVASO

View sub items for TAKING TYVASO

SUPPORT & RESOURCES

View sub items for SUPPORT & RESOURCES
  • Important Safety Information
  • Prescribing Information
  • Instructions for Use

    • The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE and return to the consumer section of the site.

    Yes, I am a US healthcare professional and would like to continue

    Continue
  • For US Healthcare Professionals

Cost assistance

ASSIST can help you determine if you qualify for United Therapeutics’ patient assistance programs.
Call ASSIST at 1-877-864-8437.

Pay as little as $5 per prescription

With the Co-Pay Assistance Card, eligible patients taking TYVASO who enroll may pay as little as a $5 co-pay per month and may receive up to $8000 in savings per year.*

Enroll today

Learn how to enroll at www.UTcopay.com or call ASSIST at 1-877-864-8437.

Get full Program details and Terms and Conditions.

Get Details

*Eligibility requirements for this Program are:

  • You must be 18 years or older to use this Program
  • The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication
  • Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible
  • Eligible patients must be a resident of the United States or Puerto Rico
  • The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program

IMPORTANT SAFETY
INFORMATION

Before you take TYVASO, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have bleeding problems
  • Are pregnant or plan to become pregnant. It is not known if TYVASO will harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if TYVASO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with TYVASO.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TYVASO and other medicines may affect each other.

Especially tell your healthcare provider if you take:

  • Medicines used to treat high blood pressure or heart disease
  • Medicines that decrease blood clotting (anticoagulants)
  • Water pills (diuretics)
  • Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)

What are the possible side effects of TYVASO?

TYVASO can cause serious side effects, including:

  • Low blood pressure (symptomatic hypotension). If you have low blood pressure, TYVASO may lower your blood pressure more.
  • Bleeding problems. TYVASO may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).

The most common side effects of TYVASO are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness and diarrhea. These are not all the possible side effects of TYVASO. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

What is TYVASO?

TYVASO (treprostinil) is a prescription medicine used in adults to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO can improve the ability to exercise.

The risk information provided here is not comprehensive. To learn more about TYVASO, talk with your healthcare provider. Please see Full Prescribing Information, the TD-100 and TD-300 TYVASO® Inhalation System Instructions for Use manuals, and other additional information at www.tyvaso.com or call 1-877-UNITHER (1-877-864-8437).

EXPAND

IMPORTANT SAFETY
INFORMATION

COLLAPSE

Before you take TYVASO, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have bleeding problems
  • Are pregnant or plan to become pregnant. It is not known if TYVASO will harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if TYVASO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with TYVASO.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TYVASO and other medicines may affect each other.

Especially tell your healthcare provider if you take:

  • Medicines used to treat high blood pressure or heart disease
  • Medicines that decrease blood clotting (anticoagulants)
  • Water pills (diuretics)
  • Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)

What are the possible side effects of TYVASO?

TYVASO can cause serious side effects, including:

  • Low blood pressure (symptomatic hypotension). If you have low blood pressure, TYVASO may lower your blood pressure more.
  • Bleeding problems. TYVASO may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).

The most common side effects of TYVASO are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness and diarrhea. These are not all the possible side effects of TYVASO. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

What is TYVASO?

TYVASO (treprostinil) is a prescription medicine used in adults to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO can improve the ability to exercise.

The risk information provided here is not comprehensive. To learn more about TYVASO, talk with your healthcare provider. Please see Full Prescribing Information, the TD-100 and TD-300 TYVASO® Inhalation System Instructions for Use manuals, and other additional information at www.tyvaso.com or call 1-877-UNITHER (1-877-864-8437).

TYVISIconAPR2021(PH-ILD)

TYVISIconAPR2021(PH-ILD)

Drug Discard ProgramPrivacy PolicyTerms of UseContact UsSite Map

TYVASO is a registered trademark of United Therapeutics Corporation.

All other brands are trademarks of their respective owners. The makers of these brands are not affiliated with and do not endorse United Therapeutics or its products.

© 2021 United Therapeutics Corporation. All rights reserved. US/TYV/0454

YOU ARE NOW LEAVING THE TYVASO.COM WEBSITE

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to tyvaso.com

Close
Continue